GlassScriptPhysician profile
Thomas Krall
NPI 1568719326
$523.17
in general payments reported to CMS, 2019-2025
13 companies · $51.83 in 2025
The $51.83 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.63 · 2022: $138 · 2023: $145 · 2024: $175 · 2025: $51.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $144.41 | 2021-2025 | Bridion |
| Edwards Lifesciences Corporation | $100.77 | 2022-2024 | Hemosphere, Mitris Resilia Mitral Valve |
| Haemonetics Corporation | $61.97 | 2023-2024 | Teg6s Hemostasis System |
| Baxter Healthcare | $46.71 | 2024 | Floseal |
| Fisher & Paykel Healthcare INC | $29.31 | 2023 | Fisher & Paykel Healthcare |
| Medtronic, INC. | $25.91 | 2022 | |
| Csl Behring | $25.21 | 2022 | |
| Artivion, INC. | $19.66 | 2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Cryovalve Sg Pulmonary Human Heart Valve, Bioglue Surgical Adhesive |
| Pacira Pharmaceuticals Incorporated | $15.84 | 2022 | |
| Chiesi USA, INC. | $14.80 | 2022 | |
| Amgen INC. | $14.38 | 2022 | |
| La Jolla Pharmaceutical Company | $14.30 | 2024 | Giapreza |
| Pajunk Medical Systems, LP | $9.90 | 2025 | E-Cath II Plus Tsui |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Krall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.